Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Archives of Disease in Childhood|December 21, 2014
The diagnosis and management of antibiotic allergy in children: Systematic review to inform a contemporary approachTom Marrs, Adam T Fox, Gideon Lack, et al.
Pediatric Pulmonology|July 27, 2004
Reduced eosinophil pro-fibrogenic effect in severe childhood asthma compared to mild disease: an effect of corticosteroids?Ilaria Puxeddu, Gideon Lack, Susan J Smith, et al.
The Annals of Otology, Rhinology, and Laryngology|September 30, 2005
Medical treatment for rhinosinusitis associated with adenoidal hypertrophy in children: an evaluation of clinical response and changes on magnetic resonance imagingChristos Georgalas, Karen Thomas, Catherine Owens, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 3, 2008
Clinical features and natural history of physical urticaria in childrenGulamabbas Khakoo, Aikaterini Sofianou-Katsoulis, Michael R Perkin, et al.
JAMA Pediatrics|November 26, 2019
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical TrialSusan Chan, Victoria Cornelius, Suzie Cro, et al.
Annual Review of Cell and Developmental Biology|July 8, 2020
Pediatric Allergic Diseases, Food Allergy, and Oral ToleranceKirsty Logan, George Du Toit, Mattia Giovannini, et al.
Clinical and Translational Allergy|April 5, 2016
The expression of CD123 can decrease with basophil activation: implications for the gating strategy of the basophil activation testAlexandra F Santos, Natalia Bécares, Alick Stephens, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2003
Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled studyGraham Roberts, Neeta Patel, Francesca Levi-Schaffer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2019
Preventing Peanut Allergy: Where Are We Now?Helen R Fisher, Corinne A Keet, Gideon Lack, et al.
Trials|May 25, 2017
The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis planTao Chen, Susan Chan, Gideon Lack, et al.
Pageof 17